ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today ...

ViiV & MPP extend voluntary licensing long-acting injectable HIV treatment, Indian pharma to benefit: Our Bureau, Bengaluru Tuesday, July 15, 2025, 12:45 Hrs [IST] ViiV Healthcare ...

Plaintiffs allege that CRISP and its subsidiary willfully infringed on patented technology by launching a copycat product after terminating a long-standing licensing agreement.

Sun recieved approval from the US Food and Drug Administration for Leqselvi in July 2024. Soon after the regulator’s approval ...

The VDP Pool from AccessAdvance has successfully attracted a group of licensees/licensors including ByteDance, Kuaishou, NTT ...

After resolving a patent dispute with Incyte, Sun Pharma has officially launched its JAK inhibitor Leqselvi in the U.S. | Sun ...

China-based biotech CARsgen Therapeutics (HKEX: 2171) has strengthened its grip on intellectual property in the CAR-T space ...

Poised for Immediate Commercial Deployments and Licensing OpportunitiesCORNELIUS, N.C., July 09, 2025 (GLOBE NEWSWIRE) -- ...

The Inner House of the Court of Session has refused a reclaiming motion against a decision that the licensee of several patents owned by a UK company was liable to pay royalties until the end of the ...

How can countries foster pharmaceutical innovation without making life-saving medicines inaccessible? India’s experience offers a compelling answer and in 2025, the country will mark 20 years since it ...